juin 2018

Nizoral North America

Nizoral North America

Exclusive Financial Advisor (Sell side)

Exclusive Financial Advisor to Johnson & Johnson on the Sale of the Rights of Nizoral in North America and Latin America to Kramer Laboratories, a Portfolio Company of Avista Capital

More Like This

novembre 2024

Smiths News

Appointed as Joint Broker
£31m

septembre 2024

Kitwave

Nominated Adviser, Sole Bookrunner and Broker (Placement)
US$235m

août 2024

Lassonde

Exclusive Financial Advisor to Lassonde on its Acquisition of Summer Garden Food Manufacturing

Afficher les transactions Consumer and Retail